Stem Q4 revenue falls 15% to USD 47.2 million

Reuters
03/05
Stem Q4 revenue falls 15% to USD 47.2 million

Stem reported Q4 2025 revenue of USD 47.2 million (down 15%) and GAAP gross profit of USD 23.2 million, with a 49% GAAP gross margin. Q4 net loss was USD 16.0 million and adjusted EBITDA was USD 5.5 million. For FY 2025, revenue was USD 156.3 million (up 8%), GAAP gross profit was USD 60.0 million (38% GAAP gross margin), net income was USD 137.8 million, and adjusted EBITDA was USD 6.7 million. Year-end FY 2025 ARR was USD 61.1 million, CARR was USD 67.2 million, contracted backlog was USD 21.3 million, and FY 2025 bookings were USD 131.8 million (up 14%); Q4 2025 bookings were USD 32.7 million. Stem ended Q4 2025 with USD 48.9 million in cash and cash equivalents. In business updates, Stem highlighted the launch of PowerTrack EMS and PowerTrack Sage, and said PowerTrack EMS was selected for Everyray projects totaling 100 MWh of utility-scale BESS in Germany, with commercial operations expected in summer 2026. The company also cited a partnership to operate and optimize a four-site BESS portfolio serving a local water utility in Southern California following a transition from a previous service provider. Stem’s board was expanded from seven to eight directors and CEO Arun Narayanan was appointed as a Class I director effective December 1, 2025. For FY 2026, Stem guided revenue of USD 140–190 million, adjusted EBITDA of USD 10–15 million, non-GAAP gross margin of 40%–50%, operating cash flow of USD 0–10 million, and year-end ARR of USD 65–70 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stem Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260304509748) on March 04, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10